Trump’s rescheduling of marijuana is a spark for top marijuana ETFs
After amassing enormous losses over the past five years, cannabis stocks received a much-needed shot in the arm last week when President Donald Trump announced plans to officially reschedule marijuana …
2 Medical Marijuana Stocks to Buy Now
Trulieve Cannabis and Green Thumb Industries are already two of the top cannabis retailers in the U.S. The Department of Justice reclassification makes them even stronger.
Tilray Brands to expand into the US marijuana market? Why you shouldn’t count on that anytime soon
Marijuana rescheduling may have taken place in the U.S., but that doesn’t mean legalization will happen anytime soon.
Marijuana Companies Eye Investment Boom After Trump Admin Reschedules Drug
Following the recent drug rescheduling from the Trump Administration, medicinal marijuana companies are preparing to raise nearly $20 million in private funding.
3 Cannabis Stocks That Could Soar After Marijuana Rescheduling
These companies are major players in the U.S. marijuana market, and they all generated more than $1 billion in revenue last year.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
3 Cannabis Stocks That Could Soar After Marijuana Rescheduling
These companies are major players in the U.S. marijuana market, and they all generated more than $1 billion in revenue last year.
This Trump Policy Shift Could Be a Game Changer for Cannabis Stocks: 2 Stocks to Watch Now
The cannabis industry has spent years navigating regulatory uncertainty, limiting the growth and profitability of marijuana companies despite strong demand. However, a fresh policy push from President …
Canopy Growth Is Rallying Again. But Is It a Dead Cat Bounce?
Canopy Growth (NASDAQ: CGC) is a Canadian marijuana company. When it first came public marijuana was a hot sector, but investor enthusiasm has waned. The stock has since declined to the point where it …
Trump just eased federal marijuana laws. Is there an investment case for cannabis ETFs right now?
Gradual easing of restrictions on marijuana continues.
Medical marijuana reclassified as less dangerous drug. Pot stocks go up in smoke
The Trump administration also announced the beginning of an expedited administrative hearing process to consider the rescheduling marijuana more broadly.
What the Trump administration’s move to reclassify marijuana means for investors
The Department of Justice said it will immediately move FDA-approved marijuana from Schedule I to Schedule III under the Controlled Substances Act.
Finally. Marijuana Gets Reclassified, but Are Pot Stocks Still Too Risky?
Markets don’t usually wait for permission — they anticipate it. That’s why cannabis stocks jumped ahead of the official news that the Justice Dept. would reclassify marijuana from Schedule I to …
How does marijuana rescheduling affect cannabis companies now?
Some operators are seeking partnerships for clinical studies, while others are developing strategies to scale their operations.
Cannabis MSOs to see increased investment, lower taxes from reclassification
Marijuana’s Schedule III shift could boost cannabis MSOs via new capital access and Section 280E tax relief. Read more here.
Recent Comments